Massive 10-Year study aims to unlock secrets of rare lung disease
NCT ID NCT06036719
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for children and adults with interstitial lung disease, a group of conditions that scar the lungs and make breathing hard. Researchers will follow 3000 patients and their relatives for up to 10 years, collecting medical data and genetic information. The goal is to learn more about how the disease starts and progresses, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
RaDiCo-ILD2
RECRUITINGParis, Île-de-France Region, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a JAK inhibitor halt rapid lung decline?
- Could a vibrating platform help people with stiff lungs breathe easier?
- Massive study tracks lung disease progression in 4,000 patients
- New MRI method could spot lung damage without radiation
- New pill aims to halt lung scarring in thousands
- New combo therapy aims to halt lung scarring in scleroderma